2-(2-(Difluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 10g

2-(chloromethyl)-3-methylquinoxaline, 95.0%, 250mg

2-Amino-1H-benzo[d]imidazol-5-ol, 95.0%, 1g

4-((5-Bromopyridin-2-yl)methyl)morpholine, 95.0%, 500mg

3-ethenyl-4-fluoropyridin-2-ol, 97.0%, 500mg

3,4-DIBROMOTHIOPHENE-2,5-DICARBALDEHYDE, 95%, 1g

Afnio ICP soluzione standard, ROTI®Star, 1000 mg/l Hf, densità (D) 1,008 g/cm³

5-Chloro-2-methylindole>98.0%(GC)(T)5g

4-Methylumbelliferyl-N-acetyl-alpha-D-neuraminic Acid Sodium Salt>95.0%(HPLC)50mg

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(3-bromophenyl)butanoic acid, 97%, 100mg

4,7-Dibromo-5,6-didodecoxy-2,1,3-benzothiadiazole, 97%, 5g

7-Chloro-4-methyl-1H-indole, 95.0%, 1g

(S)-3-(1-Fmoc-pyrrolidin-2-yl)propionic acid, 99.0%, 250mg